A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.
Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...
It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...
In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...
Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.
Studies suggest collagen supplementation may help improve conditions such as osteoarthritis, osteoporosis, sarcopenia, ...
Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD exacerbation in adults with the disease and type 2 diabetes, researchers ...
Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...
Age differences are seen in the efficacy of treatments for type 2 diabetes, according to a study published online Feb ...
These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback